Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
Q3 2025 vs. Q2 2025
How the institutions holding Silence Therapeutics plc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 55 | 54 | −1 |
| Shares | 19.8M | 19.7M | −55.2K (−0.3%) |
| Value | $108.0M | $96.4M | −$11.6M (−10.7%) |
New holders (6)
Institutions that held Silence Therapeutics plc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 22,644 | $117.5K | 0.00% |
| Citadel Advisors LLC | 21,505 | $111.6K | 0.00% |
| HRT Financial LP | 10,887 | $56.0K | 0.00% |
| EHP Funds Inc. | 10,673 | $55.4K | 0.07% |
| Acadian Asset Management LLC | 4,218 | $21.0K | 0.00% |
| Rockefeller Capital Management L.P. | 45 | $234 | 0.00% |
Sold out (7)
Institutions that held Silence Therapeutics plc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Jane Street Group, LLC | 37,813 | $219.3K |
| Saturn V Capital Management LLC | 34,737 | $201.5K |
| Susquehanna International Group, LLP | 27,797 | $161.2K |
| Massar Capital Management, LP | 19,863 | $115.2K |
| Rathbone Brothers plc | 18,421 | $106.8K |
| Beacon Pointe Advisors, LLC | 11,615 | $67.4K |
| EverSource Wealth Advisors, LLC | 10 | $58 |